Kenvue touched its 52-week high of $25.17 on May 8 and is currently trading 13.2% below that peak. Over the past three months, KVUE stock has plunged nearly 7%, significantly underperforming the ...

Throughout the last three months, 6 analysts have evaluated Kenvue (NYSE:KVUE), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their ...

Kenvue: Tylenol Can't Ease The Pain, Pricey Stock, Dividend In Vain Jul. 22, 2025 5:30 AM ET Kenvue Inc. (KVUE) Stock JNJ, KVUE Alan Galecki 233 Follower s ...

Shares of Kenvue Inc. KVUE rallied 2.15% to $21.85 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.32% to 6,263.70 ...

Kenvue, the owner of Band-Aid and Tylenol, said it had appointed director Kirk Perry as interim CEO, effectively immediately.© Patrick T. Fallon/AFP via Getty Images ...

Kenvue generated $1.3 billion in free cash flow in 2024 (roughly 9% of sales), and we forecast $2.7 billion of free cash flow by 2029 (roughly 15% of sales).

LIVE UPDATES | CONCLUDED Stock Market News, July 14, 2025: Trump Threatens 100% Tariffs on Russia Last Updated: Jul 14, 2025, 11:24 PM EDT Updated 21 days ago ...

Kenvue will report its full quarterly results on Aug. 7 and said that it will revise its full-year outlook on that date. Shares rose more than 4% before the market open.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, and a low estimate of $22.00. This current average has decreased by 0. ...

Shares of Kenvue Inc. KVUE rallied 2.44% to $22.67 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...